$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi

$opi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000145677223000029 Filed on April 26, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$134.0M	$132.4M	$147.4M
YoY Change	-5.18%	-10.13%	1.98%
Cost Of Revenue	$42.54M	$41.39M	$44.01M
YoY Change	-1.27%	-5.95%	5.79%
Gross Profit	$91.46M	$91.03M	$103.3M
YoY Change	-6.9%	-11.92%	0.43%
Gross Profit Margin	68.26%	68.74%	70.13%
Selling, General & Admin	$11.53M	$13.19M	$12.57M
YoY Change	-10.66%	4.88%	-28.98%
% of Gross Profit	12.6%	14.48%	12.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$49.48M	$24.95M	$24.97M
YoY Change	-11.81%	-0.07%	15.42%
% of Gross Profit	54.1%	27.4%	24.16%
Operating Expenses	$63.13M	$64.88M	$73.04M
YoY Change	-10.38%	-11.18%	-10.6%
Operating Profit	$28.33M	$26.16M	$30.31M
YoY Change	1.93%	-13.7%	42.95%
Interest Expense	$26.53M	$25.23M	$27.44M
YoY Change	0.04%	-8.05%	-4.72%
% of Operating Profit	93.62%	96.47%	90.54%
Other Income/Expense, Net
YoY Change
Pretax Income	-$11.34M	$418.0K	-$12.03M
YoY Change	-26.43%	-103.47%	-131.09%
Income Tax	$211.0K	$30.00K	$531.0K
% Of Pretax Income		7.18%
Net Earnings	-$12.24M	-$446.0K	-$13.41M
YoY Change	-23.75%	-96.67%	-135.41%
Net Earnings / Revenue	-9.14%	-0.34%	-9.1%
Basic Earnings Per Share	-$0.25	-$0.01	-$0.28
Diluted Earnings Per Share	-$0.25	-$0.01	-$0.28
COMMON SHARES
Basic Shares Outstanding	48.56M shares	48.56M shares	48.24M shares
Diluted Shares Outstanding	48.35M shares	48.34M shares	48.24M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.21M	$23.34M	$97.66M
YoY Change	-3.05%	-76.1%	-47.07%
Cash & Equivalents	$25.21M	$23.34M	$97.66M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$110.6M	$107.0M	$106.9M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$135.8M	$130.3M	$204.5M
YoY Change	4.98%	-36.29%	-26.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.749B	$3.754B	$3.836B
YoY Change	0.43%	-2.14%	9.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$37.37M	$36.56M	$35.01M
YoY Change	5.83%	4.42%	-6.39%
Other Assets	$95.03M	$77.38M	$114.0M
YoY Change	-41.47%	-32.1%	3.98%
Total Long-Term Assets	$3.892B	$3.877B	$3.993B
YoY Change	-1.06%	-2.92%	8.71%
TOTAL ASSETS
Total Short-Term Assets	$135.8M	$130.3M	$204.5M
Total Long-Term Assets	$3.892B	$3.877B	$3.993B
Total Assets	$4.028B	$4.007B	$4.198B
YoY Change	-0.86%	-4.54%	6.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$134.4M	$141.1M	$136.0M
YoY Change	-0.06%	3.74%	31.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$140.7M	$148.5M	$143.9M
YoY Change	-0.37%	3.24%	22.98%
LONG-TERM LIABILITIES
Long-Term Debt	$2.538B	$2.485B	$2.580B
YoY Change	2.05%	-3.68%	17.02%
Other Long-Term Liabilities	$12.92M	$14.07M	$16.93M
YoY Change	-32.1%	-16.91%	67.66%
Total Long-Term Liabilities	$2.551B	$2.499B	$2.597B
YoY Change	1.79%	-3.77%	17.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$140.7M	$148.5M	$143.9M
Total Long-Term Liabilities	$2.551B	$2.499B	$2.597B
Total Liabilities	$2.692B	$2.647B	$2.741B
YoY Change	1.68%	-3.4%	17.54%
SHAREHOLDERS EQUITY
Retained Earnings	$156.9M	$169.2M	$162.3M
YoY Change	7.29%	4.22%	-26.81%
Common Stock	$2.621B	$2.620B	$2.618B
YoY Change	0.08%	0.09%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.336B	$1.360B	$1.457B
YoY Change
Total Liabilities & Shareholders Equity	$4.028B	$4.007B	$4.198B
YoY Change	-0.86%	-4.54%	6.2%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$12.24M	-$446.0K	-$13.41M
YoY Change	-23.75%	-96.67%	-135.41%
Depreciation, Depletion And Amortization	$49.48M	$24.95M	$24.97M
YoY Change	-11.81%	-0.07%	15.42%
Cash From Operating Activities	$36.33M	$51.90M	$50.27M
YoY Change	-38.06%	3.25%	-13.25%
INVESTING ACTIVITIES
Capital Expenditures	$72.06M	$66.67M	-$36.23M
YoY Change	-236.18%	-284.01%	136.79%
Acquisitions
YoY Change
Other Investing Activities	$5.915M	$2.849M	$27.45M
YoY Change	-86.73%	-89.62%	-78.76%
Cash From Investing Activities	-$66.14M	-$63.82M	-$8.784M
YoY Change	694.24%	626.5%	-107.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.29M	$23.01M	-$26.94M
YoY Change	-126.55%	-185.42%	-1.03%
NET CHANGE
Cash From Operating Activities	36.33M	$51.90M	$50.27M
Cash From Investing Activities	-66.14M	-$63.82M	-$8.784M
Cash From Financing Activities	32.29M	$23.01M	-$26.94M
Net Change In Cash	2.478M	$11.10M	$14.54M
YoY Change	-103.48%	-23.71%	-89.94%
FREE CASH FLOW
Cash From Operating Activities	$36.33M	$51.90M	$50.27M
Capital Expenditures	$72.06M	$66.67M	-$36.23M
Free Cash Flow	-$35.73M	-$14.77M	$86.50M
YoY Change	-132.03%	-117.07%	18.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001456772
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-34364
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	OFFICE PROPERTIES INCOME TRUST
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-4273474
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Two Newton Place
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	255 Washington Street
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Newton
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02458-1634
CY2023Q1	dei	City Area Code CityAreaCode	617
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	219-1440
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48563709	shares
CY2023Q1	us-gaap	Land Land	817882000	usd
CY2022Q4	us-gaap	Land Land	821238000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	3176756000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	3114836000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3994638000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3936074000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	584512000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	561458000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3410126000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3374616000	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	4618000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	2516000	usd
CY2023Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	36558000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	35129000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	344064000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	369333000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23344000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12249000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	106966000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	105639000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	72762000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	73098000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	8562000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7397000	usd
CY2023Q1	us-gaap	Assets Assets	4007000000	usd
CY2022Q4	us-gaap	Assets Assets	3979977000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	245000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	195000000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	2189776000	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	2187875000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	49968000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	49917000	usd
CY2023Q1	opi	Liabilities Held For Sale Property LiabilitiesHeldForSaleProperty	568000	usd
CY2022Q4	opi	Liabilities Held For Sale Property LiabilitiesHeldForSaleProperty	73000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	141103000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	140151000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7441000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	6469000	usd
CY2023Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	13503000	usd
CY2022Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	14157000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2647359000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2593642000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48563709	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48563709	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48565644	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48565644	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	486000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	486000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2619994000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2619532000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	169160000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	169606000	usd
CY2023Q1	us-gaap	Cumulative Dividends CumulativeDividends	1429999000	usd
CY2022Q4	us-gaap	Cumulative Dividends CumulativeDividends	1403289000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1359641000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1386335000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4007000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3979977000	usd
CY2023Q1	us-gaap	Lease Income LeaseIncome	132422000	usd
CY2022Q1	us-gaap	Lease Income LeaseIncome	147354000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	15333000	usd
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	16645000	usd
CY2023Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	7260000	usd
CY2022Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	6865000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	26057000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	27363000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51692000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	60469000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	17047000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3218000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5925000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5706000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	109485000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	134095000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2548000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2149000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	164000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2205000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2404000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	25231000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	27439000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	418000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12030000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-834000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-846000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13407000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48336000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48336000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48243000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48243000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1386335000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	477000	usd
CY2023Q1	opi	Shares Granted Value Share Based Payment Arrangement Forfeited And Repurchased SharesGrantedValueShareBasedPaymentArrangementForfeitedAndRepurchased	15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	26710000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1359641000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1496709000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	415000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	1000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13407000	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	26634000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1457082000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13407000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	24947000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	24965000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2205000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2404000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24614000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	34079000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	2365000	usd
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	2106000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2548000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2149000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	17047000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	4173000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	2686000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-204000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-142000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-834000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-846000	usd
CY2023Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-2846000	usd
CY2022Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-5184000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	2841000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	7082000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1189000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	341000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4110000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11919000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	972000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1077000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51900000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50266000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	66665000	usd
CY2022Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	36229000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	51000	usd
CY2023Q1	opi	Contributions To Unconsolidated Joint Ventures ContributionsToUnconsolidatedJointVentures	2263000	usd
CY2022Q1	opi	Contributions To Unconsolidated Joint Ventures ContributionsToUnconsolidatedJointVentures	1070000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	5112000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	28464000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63816000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8784000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	305000	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	25000000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	266000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26710000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26634000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23011000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26939000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11095000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14543000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12249000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84515000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23344000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99058000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	25033000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	28630000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	41172000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	25165000	usd
CY2023Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	2106000	usd
CY2022Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	607000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23344000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97656000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	1402000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23344000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99058000	usd
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2023Q1	opi	Number Of Operating Lease Executed NumberOfOperatingLeaseExecuted	16	lease
CY2023Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period Area Of Leased Property OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriodAreaOfLeasedProperty	203000	sqft
CY2023Q1	opi	Operating Leases Weighted Average Lease Term OperatingLeasesWeightedAverageLeaseTerm	P6Y9M18D
CY2023Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriod	8747000	usd
CY2023Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period Committed But Unspent Tenant Related Obligations OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriodCommittedButUnspentTenantRelatedObligations	139874000	usd
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2023Q1	opi	Number Of Mortgage Notes NumberOfMortgageNotes	1	mortgage_note
CY2023Q1	opi	Number Of Properties Collateralized NumberOfPropertiesCollateralized	1	building
CY2023Q1	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	Our leases provide for base rent payments and in addition may include variable payments. Rental income from operating leases, including any payments derived by index or market-based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term. Allowances for bad debts are recognized as a direct reduction of rental income. In certain circumstances, some leases provide the tenant with the right to terminate if the legislature or other funding authority does not appropriate the funding necessary for the tenant to meet its lease obligations; we have determined the fixed non-cancelable lease term of these leases to be the full term of the lease because we believe the occurrence of early terminations to be a remote contingency based on both our historical experience and our assessments of the likelihood of lease cancellation on a separate lease basis.
CY2023Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	4173000	usd
CY2022Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	2686000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	90478000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	86305000	usd
CY2023Q1	us-gaap	Variable Lease Income VariableLeaseIncome	21370000	usd
CY2022Q1	us-gaap	Variable Lease Income VariableLeaseIncome	22536000	usd
CY2023Q1	opi	Tenant Reimbursement Income TenantReimbursementIncome	20066000	usd
CY2022Q1	opi	Tenant Reimbursement Income TenantReimbursementIncome	21475000	usd
CY2023Q1	opi	Aggregate Net Book Value Of Real Estate Properties Collateralized AggregateNetBookValueOfRealEstatePropertiesCollateralized	54256000	usd
CY2023Q1	opi	Aggregate Principal Amount Of Real Estate Properties Collateralized AggregatePrincipalAmountOfRealEstatePropertiesCollateralized	50000000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	975	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	opi	Stock Repurchased During Period Price Per Share StockRepurchasedDuringPeriodPricePerShare	13.50
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26710000	usd
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2023Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture

Files In Submission

Name	View Source	Status
0001456772-23-000029-index-headers.html	Edgar Link	pending
0001456772-23-000029-index.html	Edgar Link	pending
0001456772-23-000029.txt	Edgar Link	pending
0001456772-23-000029-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image1a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opi-20230331.htm	Edgar Link	pending
opi-20230331.xsd	Edgar Link	pending
opi_033123x10ex101.htm	Edgar Link	pending
opi_033123x10qex311.htm	Edgar Link	pending
opi_033123x10qex312.htm	Edgar Link	pending
opi_033123x10qex313.htm	Edgar Link	pending
opi_033123x10qex314.htm	Edgar Link	pending
opi_033123x10qex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
opi-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
opi-20230331_def.xml	Edgar Link	unprocessable
opi-20230331_lab.xml	Edgar Link	unprocessable
opi-20230331_pre.xml	Edgar Link	unprocessable
opi-20230331_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi

2023 Q2 Form 10-Q Financial Statement

#000145677223000029 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPI OFFICE PROPERTIES INCOME TRUST Stock $opi

2023 Q2 Form 10-Q Financial Statement

#000145677223000029 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi